Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-017544

Chief Legal Officer gave up 6,840 shares (to pay taxes)

  • Chief Legal Officer acquired 23,812 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2021-03-01 Option exercise +17,175 143,821 D
Ali-Jackson Kamil Chief Legal Officer 2021-03-01 Shares withheld for taxes −4,934 $24.06 $118,712 138,887 D
Ali-Jackson Kamil Chief Legal Officer 2021-03-02 Option exercise +6,637 145,524 D
Ali-Jackson Kamil Chief Legal Officer 2021-03-02 Shares withheld for taxes −1,906 $23.25 $44,315 143,618 D
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2021-03-01 Grant or award · Employee Stock Option (Right to Buy) +99,500 99,500 D
Ali-Jackson Kamil Chief Legal Officer 2021-03-01 Grant or award · Restricted stock units +28,400 28,400 D
Ali-Jackson Kamil Chief Legal Officer 2021-03-01 Option exercise · Restricted stock units −17,175 34,350 D
Ali-Jackson Kamil Chief Legal Officer 2021-03-02 Option exercise · Restricted stock units −6,637 19,914 D
Loading xslF345X03/doc4.xml…